Skip to main content

Table 2 Association between mortality and antiviral therapy, age, chronic heart disease, chronic lung disease and kidney disease

From: Trends in antiviral therapy of adults hospitalized with influenza in Canada since the end of the 2009 pandemic

Variable p-value HR*- (95% CI)
Antiviral therapy 0.63 1.12 (0.72, 1.74)
Age <0.001 1.02 (1.01, 1.03)
No chronic heart disease (reference chronic heart disease) 0.16 1.33 (0.90, 1.97)
No chronic lung disease (reference chronic lung disease) 0.93 0.98 (0.68, 1.42)
No kidney disease (reference kidney disease) 0.07 0.65 (0.42, 1.03)
  1. Note: HR = hazard ratio, CI = confidence interval.